WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003006062) PHARMACEUTICAL AGENTS CONTAINING ACYCLOVIR, FUSARIC ACID AND DERIVATIVES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/006062    International Application No.:    PCT/US2001/022228
Publication Date: 23.01.2003 International Filing Date: 11.07.2001
Chapter 2 Demand Filed:    11.02.2003    
IPC:
A61K 45/06 (2006.01)
Applicants: NOVACTYL, INC. [US/US]; 763 South New Ballas Road, Suite 204, St. Louis, MO 63141 (US) (For All Designated States Except US).
AMIN, Avinash, N. [US/US]; (US) (For US Only).
DOUGLAS, Michael, G. [US/US]; (US) (For US Only)
Inventors: AMIN, Avinash, N.; (US).
DOUGLAS, Michael, G.; (US)
Agent: AMOS, Ahaji, K.; Thompson Coburn LLP, One Firstar Plaza, St. Louis, MO 63101 (US)
Priority Data:
Title (EN) PHARMACEUTICAL AGENTS CONTAINING ACYCLOVIR, FUSARIC ACID AND DERIVATIVES THEREOF
(FR) AGENTS PHARMACEUTIQUES CONTENANT DE L'ACYCLOVIR, DE L'ACIDE FUSARIQUE ET DES DERIVES DE CET ACIDE
Abstract: front page image
(EN)Compositions are provided, which are comprised of at least one nucleoside analogue inhibito, pharmaceutically acceptable salts, solvates, or produgs thereof and fusaric acid, derivatives, or pharmaceutically acceptable salts thereof. Pharmaceutical compositions comprising the above compositions are also provided that optionally further include another therapeutically effective compound, such as a carrier. Systemic and topical preparations comprising the above compositions are also provided as well as methods of treating viral diseases by the administration of the above antiviral agents to a patient.
(FR)L'invention concerne des compositions comprenant au moins un inhibiteur, analogue de nucléoside, des sels, des solvates ou des promédicaments de cet inhibiteur, acceptables sur le plan pharmaceutique, et de l'acide fusarique, des dérivés ou des sels de cet acide, acceptables sur le plan pharmaceutique. Les compositions pharmaceutiques comprenant ces compositions peuvent aussi contenir un autre composé thérapeutiquement efficace, notamment comme support. L'invention concerne aussi des préparations générales ou locales comprenant ces compositions, ainsi que des méthodes de traitement de maladies virales consistant à administrer ces agents antiviraux à un sujet.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)